1372 related articles for article (PubMed ID: 16860018)
1. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).
Cox DA; Stone GW; Grines CL; Stuckey T; Zimetbaum PJ; Tcheng JE; Turco M; Garcia E; Guagliumi G; Iwaoka RS; Mehran R; O'Neill WW; Lansky AJ; Griffin JJ;
Am J Cardiol; 2006 Aug; 98(3):331-7. PubMed ID: 16860018
[TBL] [Abstract][Full Text] [Related]
2. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
Zhang Q; Zhang RY; Qiu JP; Zhang JF; Wang XL; Jiang L; Liao ML; Zhang JS; Hu J; Yang ZK; Shen WF
Chin Med J (Engl); 2008 Mar; 121(6):485-91. PubMed ID: 18364130
[TBL] [Abstract][Full Text] [Related]
3. Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial.
Prasad A; Stone GW; Aymong E; Zimetbaum PJ; McLaughlin M; Mehran R; Garcia E; Tcheng JE; Cox DA; Grines CL; Gersh BJ;
Am Heart J; 2004 Apr; 147(4):669-75. PubMed ID: 15077083
[TBL] [Abstract][Full Text] [Related]
4. Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial).
Dangas G; Aymong ED; Mehran R; Tcheng JE; Grines CL; Cox DA; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Lansky AJ; Stone GW;
Am J Cardiol; 2004 Oct; 94(8):983-8. PubMed ID: 15476608
[TBL] [Abstract][Full Text] [Related]
5. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and outcomes of patients with ST-segment elevation myocardial infarction excluded from the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) trial.
Fiocca L; Guagliumi G; Rossini R; Parise H; Musumeci G; Sirbu V; Lortkipanidze N; Yu J; Mihalcsik L; Vassileva A; Valsecchi O; Gavazzi A; Mehran R; Stone GW
Am J Cardiol; 2013 Jan; 111(2):196-201. PubMed ID: 23111141
[TBL] [Abstract][Full Text] [Related]
7. When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials.
Brodie BR; Gersh BJ; Stuckey T; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Grines CL; Cox D; Parise H; Prasad A; Lansky AJ; Mehran R; Stone GW
J Am Coll Cardiol; 2010 Jul; 56(5):407-13. PubMed ID: 20650362
[TBL] [Abstract][Full Text] [Related]
8. Prehospital abciximab in ST-segment elevation myocardial infarction: results of the randomized, double-blind MISTRAL study.
Ohlmann P; Reydel P; Jacquemin L; Adnet F; Wolf O; Bartier JC; Weiss A; Lapostolle F; Gaultier C; Salengro E; Benamer H; Guyon P; Chevalier B; Catan S; Ecollan P; Chouihed T; Angioi M; Zupan M; Bronner F; Bareiss P; Steg G; Montalescot G; Monassier JP; Morel O
Circ Cardiovasc Interv; 2012 Feb; 5(1):69-76, S1. PubMed ID: 22319064
[TBL] [Abstract][Full Text] [Related]
9. Outcome of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention during on- versus off-hours (a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial substudy).
Cubeddu RJ; Palacios IF; Blankenship JC; Horvath SA; Xu K; Kovacic JC; Dangas GD; Witzenbichler B; Guagliumi G; Kornowski R; Dudek D; Stone GW; Mehran R
Am J Cardiol; 2013 Apr; 111(7):946-54. PubMed ID: 23340031
[TBL] [Abstract][Full Text] [Related]
10. Comparison of outcomes and safety of "facilitated" versus primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
McKay RG; Dada MR; Mather JF; Mennet RR; Murphy DJ; Maloney KW; Hirst JA; Kiernan FJ
Am J Cardiol; 2009 Feb; 103(3):316-21. PubMed ID: 19166682
[TBL] [Abstract][Full Text] [Related]
11. Impact of angina prior to acute ST-elevation myocardial infarction on short-term outcomes after primary percutaneous coronary intervention: results from the Shanghai Registry of Acute Coronary Syndrome (SRACE).
Zhang Q; Zhang RY; Zhu TQ; Hu J; Yang ZK; Ding FH; Du R; Zhu ZB; Shen WF
Chin Med J (Engl); 2012 Mar; 125(6):977-82. PubMed ID: 22613517
[TBL] [Abstract][Full Text] [Related]
12. Aspiration thrombectomy during primary percutaneous coronary intervention as adjunctive therapy to early (in-ambulance) abciximab administration in patients with acute ST elevation myocardial infarction: an analysis from Leiden MISSION! acute myocardial infarction treatment optimization program.
Ahmed TA; Atary JZ; Wolterbeek R; Hasan-Ali H; Abdel-Kader SS; Schalij MJ; Jukema JW
J Interv Cardiol; 2012 Feb; 25(1):1-9. PubMed ID: 22059390
[TBL] [Abstract][Full Text] [Related]
13. ST-segment analysis to predict infarct size and functional outcome in acute myocardial infarction treated with primary coronary intervention and adjunctive abciximab therapy.
Sciagrà R; Parodi G; Migliorini A; Valenti R; Antoniucci D; Sotgia B; Pupi A
Am J Cardiol; 2006 Jan; 97(1):48-54. PubMed ID: 16377283
[TBL] [Abstract][Full Text] [Related]
14. Impact of stents and abciximab on survival from cardiogenic shock treated with percutaneous coronary intervention.
Huang R; Sacks J; Thai H; Goldman S; Morrison DA; Barbiere C; Ohm J
Catheter Cardiovasc Interv; 2005 May; 65(1):25-33. PubMed ID: 15800889
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction.
Wijnbergen I; Tijssen J; van 't Veer M; Michels R; Pijls NH
Catheter Cardiovasc Interv; 2013 Sep; 82(3):379-84. PubMed ID: 23553888
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial.
Zeymer U; Margenet A; Haude M; Bode C; Lablanche JM; Heuer H; Schröder R; Kropff S; Bourkaib R; Banik N; Zahn R; Teiger E
J Am Coll Cardiol; 2010 Aug; 56(6):463-9. PubMed ID: 20670755
[TBL] [Abstract][Full Text] [Related]
17. Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial).
Maioli M; Bellandi F; Leoncini M; Toso A; Dabizzi RP
J Am Coll Cardiol; 2007 Apr; 49(14):1517-24. PubMed ID: 17418289
[TBL] [Abstract][Full Text] [Related]
18. Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry).
Abbott JD; Ahmed HN; Vlachos HA; Selzer F; Williams DO
Am J Cardiol; 2007 Jul; 100(2):190-5. PubMed ID: 17631068
[TBL] [Abstract][Full Text] [Related]
19. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Tcheng JE; Kandzari DE; Grines CL; Cox DA; Effron MB; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Fahy M; Lansky AJ; Mehran R; Stone GW;
Circulation; 2003 Sep; 108(11):1316-23. PubMed ID: 12939213
[TBL] [Abstract][Full Text] [Related]
20. Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study.
Bertrand OF; Rodés-Cabau J; Larose E; Rinfret S; Gaudreault V; Proulx G; Barbeau G; Déry JP; Gleeton O; Manh-Nguyen C; Noël B; Roy L; Costerousse O; De Larochellière R;
Am J Cardiol; 2010 Jun; 105(11):1520-7. PubMed ID: 20494655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
